Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial

por Kok, Peey Sei, Forde, Patrick M, Hughes, Brett, Sun, Zhuoxin, Brown, Chris, Ramalingam, Suresh, Cook, Alistair, Lesterhuis, Willem Joost, Yip, Sonia, O’Byrne, Ken, Pavlakis, Nick, Brahmer, Julie, Anagnostou, Valsamo, Ford, Kate, Fitzpatrick, Karen, Bricker, Alison, Cummins, Michelle M, Stockler, Martin, Nowak, Anna K
Publicado 2022

Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA)

por Smith, Deborah, Robledo, Kristy P., Yip, Sonia, Cummins, Michelle M., Kok, Peey-Sei, Lee, Yeh Chen, Friedlander, Michael, Baron-Hay, Sally, Shannon, Catherine, Coward, Jermaine, Beale, Philip, Goss, Geraldine, Meniawy, Tarek, Lombard, Janine, Spurdle, Amanda B., Andrews, John, Stockler, Martin R., Mileshkin, Linda, Antill, Yoland
Publicado 2022

Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

por Jardine, Meg J, Kotwal, Sradha S, Bassi, Abhinav, Hockham, Carinna, Jones, Mark, Wilcox, Arlen, Pollock, Carol, Burrell, Louise M, McGree, James, Rathore, Vinay, Jenkins, Christine R, Gupta, Lalit, Ritchie, Angus, Bangi, Ashpak, D’Cruz, Sanjay, McLachlan, Andrew J, Finfer, Simon, Cummins, Michelle M, Snelling, Thomas, Jha, Vivekanand, Bhalla, Ashish, Fox, Gregory, Nag, Santosh Kumar, Makris, Angela, Mangos, George, Post, Jeffrey, Rao, Indu Ramachandra, Sukkar, Louisa, Sullivan, Richard, Di Tanna, Gian Luca, Trubiano, Jason, Zoungas, Sophia, Bains, Lovenish, Jindal, Atul, Nagarkar, Nitin M, Nayak, Saurabh
Publicado 2022